StockData
Bone Biologics Corp logo

Bone Biologics Corp (BBLG) stock

BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 6/30
$0.29−0.02 (-5.92%)

Close on Nov 18, 2026Market cap $986.22KP/E –Yield –

Bone Biologics r&d expenses

Research and development expenses are spending on new products and technology.

Bone Biologics's R&D Expenses for the twelve months ending Sep 30, 2026 was $950.11K, down 50.2% year over year. For fiscal 2025 it was $1.06M, down 50.2% from the year before. Over ten years it grew -11.7% a year on average. The highest annual figure on record is $10.17M in fiscal 2016.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.06M-50.2%
FY2024Dec 31, 2024$2.13M-69.2%
FY2023Dec 31, 2023$6.91M+337.4%
FY2022Dec 31, 2022$1.58M+1824.9%
FY2021Dec 31, 2021$82.04K-75.9%
FY2020Dec 31, 2020$340.67K-68.9%
FY2019Dec 31, 2019$1.10M+948.1%
FY2018Dec 31, 2018$104.49K-92.6%
FY2017Dec 31, 2017$1.42M-86.1%
FY2016Dec 31, 2016$10.17M+177.3%
FY2015Dec 31, 2015$3.67M+488.0%
FY2014Dec 31, 2014$623.52K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$242.57K+29.2%
Q2 FY2026Jun 30, 2026$308.75K+61.1%
Q1 FY2026Mar 31, 2026$141.60K-66.6%
Q4 FY2025Dec 31, 2025$257.20K-76.7%
Q3 FY2025Sep 30, 2025$187.81K-56.3%
Q2 FY2025Jun 30, 2025$191.61K-45.3%
Q1 FY2025Mar 31, 2025$423.58K+72.4%
Q4 FY2024Dec 31, 2024$1.10M+147.1%
Q3 FY2024Sep 30, 2024$429.75K-72.7%
Q2 FY2024Jun 30, 2024$350.44K-84.7%
Q1 FY2024Mar 31, 2024$245.63K-90.5%
Q4 FY2023Dec 31, 2023$447.08K+2440.2%
Q3 FY2023Sep 30, 2023$1.57M+4226.5%
Q2 FY2023Jun 30, 2023$2.30M+6547.5%
Q1 FY2023Mar 31, 2023$2.59M–
Q2 FY2022Jun 30, 2022$17.60K+773.0%
Q1 FY2022Mar 31, 2022$36.40K-20.0%
Q4 FY2021Dec 31, 2021$34.53K+59.2%
Q3 FY2021Sep 30, 2021$0-100.0%
Q2 FY2021Jun 30, 2021$2.02K-77.6%
Q1 FY2021Mar 31, 2021$45.50K-72.8%
Q4 FY2020Dec 31, 2020$21.69K-68.3%
Q3 FY2020Sep 30, 2020$142.88K+217.9%
Q2 FY2020Jun 30, 2020$9.00K-97.8%
Q1 FY2020Mar 31, 2020$167.10K-70.4%
Q4 FY2019Dec 31, 2019$68.34K-88.9%
Q3 FY2019Sep 30, 2019$44.94K–
Q2 FY2019Jun 30, 2019$417.57K+122.7%
Q1 FY2019Mar 31, 2019$564.33K+52.9%
Q4 FY2018Dec 31, 2018$613.71K+77.8%
Q3 FY2018Sep 30, 2018-$1.07M-554.9%
Q2 FY2018Jun 30, 2018$187.46K-55.8%
Q1 FY2018Mar 31, 2018$369.01K-9.3%
Q4 FY2017Dec 31, 2017$345.14K-50.5%
Q3 FY2017Sep 30, 2017$234.26K-90.5%
Q2 FY2017Jun 30, 2017$423.93K–
Q1 FY2017Mar 31, 2017$406.89K–
Q4 FY2016Dec 31, 2016$697.41K–
Q3 FY2016Sep 30, 2016$2.47M–

More Bone Biologics figures

See a number that looks wrong?